Ledger.Open graph →
SEC Form D · filed February 17, 2021

ImmunoRx Pharma, Inc

Offering
$25.4M
Sold
$2.7M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WILMINGTON, DE
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Caroline Fortier · Wilmington, DEExecMark Cipriano · Wilmington, DEExecGrant D. King · Perth, WA, Channel IslandsExecPhilip Hulse · Clayton, MOExecMarc Riviere · Westmount, Quebec, CanadaDirectorPhilippe Tessier · Lewis, Quebec, CanadaDirectorAlexandre Lebeaut · Southlake, TXDirectorPieter Van Staden · Winter Park, FLExecParin Shah · New York, NYExecMarc Riviere · Westmount, Quebec, CanadaDirectorPhilippe Tessier · Lewis, Quebec, CanadaDirectorAlexandre Lebeaut · Southlake, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗